Log In
BCIQ
Print this Print this
 

Ebernet, eberconazole 1% cream

  Manage Alerts
Collapse Summary General Information
Company Luqa Pharmaceuticals
DescriptionEberconazole 1% cream
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationFungal infection
Indication DetailsTreat fungal infection of the skin
Regulatory Designation
PartnerNewBridge Pharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/30/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today